{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:55Z","timestamp":1787010055025,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/jcp.0000000000000336","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T14:37:16Z","timestamp":1432823836000},"page":"460-463","source":"Crossref","is-referenced-by-count":16,"title":["Increase of Heart Rate and QTc by Amitriptyline, But Not by Venlafaxine, Is Correlated to Serum Concentration"],"prefix":"10.1097","volume":"35","author":[{"given":"Stefan","family":"Unterecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pfuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Kopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kittel-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210128","first-page":"687","article-title":"QTc prolongation by psychotropic drugs and the risk of torsade de pointes.","volume":"108","author":"Wenzel-Seifert","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"R2-19-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/DHPS.S28804","article-title":"Clinical use of antidepressant therapy and associated cardiovascular risk.","volume":"4","author":"Waring","year":"2012","journal-title":"Drug Healthc Patient Saf"},{"key":"R3-19-20210128","doi-asserted-by":"crossref","first-page":"f288","DOI":"10.1136\/bmj.f288","article-title":"QT interval and antidepressant use: a cross sectional study of electronic health records.","volume":"346","author":"Castro","year":"2013","journal-title":"BMJ"},{"key":"R4-19-20210128","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients.","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"R5-19-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/JCP.0b013e318191c6a8","article-title":"Psychotropic drugs associated with corrected QT interval prolongation.","volume":"29","author":"van Noord","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R6-19-20210128","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/pds.3479","article-title":"Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study.","volume":"22","author":"Iribarren","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R7-19-20210128","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00007691-200108000-00019","article-title":"Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.","volume":"23","author":"Rodriguez de la Torre","year":"2001","journal-title":"Ther Drug Monit"},{"key":"R8-19-20210128","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.psy.45.5.371","article-title":"Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.","volume":"45","author":"Vieweg","year":"2004","journal-title":"Psychosomatics"},{"key":"R9-19-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psym.2012.11.001","article-title":"QTc prolongation, torsades de pointes, and psychotropic medications.","volume":"54","author":"Beach","year":"2013","journal-title":"Psychosomatics"},{"key":"R10-19-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/s-0032-1308969","article-title":"Pharmacotherapeutic determinants for QTc interval prolongation in Japanese patients with mood disorder.","volume":"45","author":"Okayasu","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"R11-19-20210128","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00637499","article-title":"Overdosage of antidepressants: clinical and pharmacokinetic aspects.","volume":"23","author":"Pedersen","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"R12-19-20210128","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1060028013501994","article-title":"A comparison of the risk of QT prolongation among SSRIs.","volume":"47","author":"Funk","year":"2013","journal-title":"Ann Pharmacother"},{"key":"R13-19-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.13m08397","article-title":"QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.","volume":"75","author":"van Haelst","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"R14-19-20210128","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0031-1286346","article-title":"Correlation of QTc interval prolongation and serum level of citalopram after intoxicationa case report.","volume":"45","author":"Unterecker","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"R15-19-20210128","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijcard.2005.03.065","article-title":"QT interval prolongation associated with venlafaxine administration.","volume":"109","author":"Letsas","year":"2006","journal-title":"Int J Cardiol"},{"key":"R16-19-20210128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","article-title":"Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database.","volume":"31","author":"Reis","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R17-19-20210128","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-012-0952-2","article-title":"Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions.","volume":"120","author":"Unterecker","year":"2013","journal-title":"J Neural Transm"},{"key":"R18-19-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157488610789869265","article-title":"QT alterations in psychopharmacology: proven candidates and suspects.","volume":"5","author":"Alvarez","year":"2010","journal-title":"Curr Drug Saf"},{"key":"R19-19-20210128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/clc.20945","article-title":"Acquired long QT interval: a case series of multifactorial QT prolongation.","volume":"34","author":"Digby","year":"2011","journal-title":"Clin Cardiol"},{"key":"R20-19-20210128","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ng1790","article-title":"A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization.","volume":"38","author":"Arking","year":"2006","journal-title":"Nat Genet"},{"key":"R21-19-20210128","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1073\/pnas.96.2.657","article-title":"Nitric oxide synthase in cardiac sarcoplasmic reticulum.","volume":"96","author":"Xu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-19-20210128","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.106.676783","article-title":"Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam study.","volume":"116","author":"Aarnoudse","year":"2007","journal-title":"Circulation"},{"key":"R23-19-20210128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000103630","article-title":"Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish.","volume":"64","author":"Post","year":"2007","journal-title":"Hum Hered"},{"key":"R24-19-20210128","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/ije\/dyn091","article-title":"Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.","volume":"37","author":"Tobin","year":"2008","journal-title":"Int J Epidemiol"},{"key":"R25-19-20210128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2796.2008.02026.x","article-title":"Common candidate gene variants are associated with QT interval duration in the general population.","volume":"265","author":"Marjamaa","year":"2009","journal-title":"J Intern Med"},{"key":"R26-19-20210128","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.108.791723","article-title":"Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.","volume":"119","author":"Kao","year":"2009","journal-title":"Circulation"},{"key":"R27-19-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0006138","article-title":"Common genetic variation near the phospholamban gene is associated with cardiac repolarization: meta-analysis of three genome-wide association studies.","volume":"4","author":"Nolte","year":"2009","journal-title":"PLoS One"},{"key":"R28-19-20210128","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng.364","article-title":"Common variants at ten loci influence QT interval duration in the QTGEN study.","volume":"41","author":"Newton-Cheh","year":"2009","journal-title":"Nat Genet"},{"key":"R29-19-20210128","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCGENETICS.108.833806","article-title":"A genome-wide association scan of RR and QT interval duration in 3 European genetically isolated populations: the EUROSPAN project.","volume":"2","author":"Marroni","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"R30-19-20210128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCGENETICS.112.962787","article-title":"Impact of ancestry and common genetic variants on QT interval in African Americans.","volume":"5","author":"Smith","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"R31-19-20210128","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.362","article-title":"Common variants at ten loci modulate the QT interval duration in the QTSCD study.","volume":"41","author":"Pfeufer","year":"2009","journal-title":"Nat Genet"},{"key":"R32-19-20210128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/07853890802392529","article-title":"Common variants in NOS1AP and KCNH2 genes and QT interval duration in young adults. The cardiovascular risk in young finns study.","volume":"41","author":"Raitakari","year":"2009","journal-title":"Ann Med"},{"key":"R33-19-20210128","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1464-5491.2010.03072.x","article-title":"A common variant of NOS1AP is associated with QT interval duration in a Chinese population with type 2 diabetes.","volume":"27","author":"Lu","year":"2010","journal-title":"Diabet Med"},{"key":"R34-19-20210128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/ddn341","article-title":"Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration.","volume":"18","author":"Eijgelsheim","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R35-19-20210128","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1540-8159.2010.02973.x","article-title":"Henry Cuthbert Bazett (1885-1950)the man behind the QT interval correction formula.","volume":"34","author":"Roguin","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"R36-19-20210128","first-page":"287","article-title":"Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice.","volume":"72","author":"Pfuhlmann","year":"2007","journal-title":"J Neural Transm"},{"key":"R37-19-20210128","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1038\/npp.2008.17","article-title":"Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.","volume":"33","author":"Childs","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R38-19-20210128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0000000000000336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:48:36Z","timestamp":1620942516000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201508000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0000000000000336","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}